|
시장보고서
상품코드
1360050
북미의 임상시험 이미징 시장 예측(-2028년) : 지역별 분석 - 모달리티, 오퍼링, 최종사용자별North America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User |
||||||
북미의 임상시험 이미징 시장은 2023년 7억 494만 달러에서 2028년에는 10억 2,561만 달러로 성장할 것으로 예측되며, 2023-2028년의 CAGR은 7.8%로 추정됩니다.
의료 영상 서비스를 제공하는 CRO 수의 급증이 북미 임상시험 영상 시장을 지원
임상연구기관(CRO)은 양질의 시설과 전문성을 바탕으로 제공하는 서비스를 통해 임상시험의 성공을 돕고 있으며, CRO는 효율적이고 비용 효율적인 운영을 통해 임상시험 의뢰자에게 이익을 가져다주며 임상시험 산업의 중추적인 역할을 하고 있습니다. 예를 들어 CRO가 임상시험을 수행하고 완료하는 데 소요되는 시간은 사내 활동보다 평균 30% 더 짧으며, CRO의 수가 증가하고 경쟁이 치열해짐에 따라 일부 CRO는 이미징에 특화된 서비스를 제공하면서 이미징 CRO(iCRO)로 부상하고 있습니다. iCRO의 예로는 Keosys Medical Imaging, Medica Group PLC 등이 있으며, CRO는 이미징 수행기관 인증, 표준화된 영상 획득, 판독 설계 및 기준 결정 등의 분야에서 중요한 지식을 제공함으로써 북미 임상시험 이미징 시장 성장에 기여하고 있습니다. 성장에 기여하고 있습니다.
북미 임상시험 이미징 시장 개요
북미 임상시험 이미징 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국은 임상시험 이미징 시장에서 가장 크고 빠르게 성장하고 있는 시장입니다. 이 지역 시장 성장은 미국이 주요 임상 연구 지역으로 부상하고 있으며, 임상시험에 적용하기 위한 기업의 혁신적인 제품 출시가 증가하고 있기 때문입니다. 미국은 주요 임상 연구 지역으로 부상하고 있습니다. 세계에서 진행되는 임상시험의 약 절반이 미국에서 이루어지고 있습니다. 또한 대부분의 제약 연구 기업은 잘 구축된 의료 인프라, 신속한 승인 일정, 유리한 규제 프레임워크, 임상시험에서 얻은 데이터의 수용성 등의 이유로 미국에서의 임상시험 수행을 선호합니다.
북미 임상시험 이미징 시장 매출 및 2028년까지의 예측(금액)
북미 임상시험 이미징 시장 세분화
북미 임상시험 이미징 시장은 양식, 제품, 최종사용자 및 국가별로 분류됩니다.
양상별로 북미 임상시험 영상 시장은 단층촬영, 자기공명영상(MRI), 초음파, 양전자방출단층촬영(PET), 엑스레이, 심초음파, 기타로 구분되며, 2023년에는 단층촬영 부문이 가장 큰 시장 점유율을 기록할 것으로 예상됩니다.
북미 임상시험 이미징 시장은 제공 서비스를 기준으로 운영 이미징 서비스, 이미징 소프트웨어, 판독 및 분석 서비스, 시험 설계 및 컨설팅 서비스, 기타로 분류됩니다. 운영 이미징 서비스 부문이 2023년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
최종사용자별로 북미 임상시험 이미징 시장은 위탁연구기관(CRO), 제약 및 생명공학 기업, 학술 및 연구기관, 기타로 구분되며, 2023년에는 위탁연구기관(CRO) 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
국가별로 보면 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국이 2023년의 시장 점유율을 독점했습니다.
BioTelemetry Inc, Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Medpace Holdings Inc, VIDA Diagnostics Inc, WCG Clinical Inc가 북미 임상시험 이미징 시장에서 사업을 운영하는 주요 기업입니다.
목차
제1장 서론
제2장 북미 임상시험 이미징 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 북미의 임상시험 이미징 시장 - 시장 구도
- 북미 PEST 분석
- 전문가의 견해
제5장 북미의 임상시험 이미징 시장 : 주요 시장 역학
- 시장 촉진요인
- 제약·바이오테크놀러지 업계에서 임상시험 활동의 가속
- 메디컬 이미징 서비스를 제공하는 CRO 수의 급증
- 시장 억제요인
- 고액 투자와 표준화된 인프라 요건
- 시장 기회
- 인실리코 이미징 임상시험
- 향후 동향
- AI 주도형 임상시험
- 영향 분석
제6장 북미 임상시험 이미징 시장
- 북미 임상시험 이미징 시장 매출과 예측 분석
제7장 북미 임상시험 이미징 시장 매출과 2028년까지의 예측 - 모달리티별
- 북미 임상시험 이미징 시장 모달리티별 매출 점유율(2022년, 2028년)
- 토모그래피
- 초음파
- PET(Positron Emission Tomography)
- X선
- 심에코
- 자기공명영상법
- 기타
제8장 북미 임상시험 이미징 시장 매출과 2028년까지의 예측 - 제공
- 북미 임상시험 이미징 시장 오퍼링별 매출 점유율(2022년 및 2028년)
- 임상시험 디자인 컨설팅 서비스
- Read Analysis Services
- 이미징 운영 서비스
- 이미징 소프트웨어
- 기타
제9장 북미 임상시험 이미징 시장 매출과 2028년까지의 예측 - 최종사용자별
- 제약회사 및 바이오 제약회사
- 계약 연구기관
- 학술·연구기관
- 기타
제10장 북미의 임상시험 이미징 시장 : 매출과 2028년까지의 예측 : 국가별 분석
- 북미
- 미국
- 캐나다
- 멕시코
제11장 임상시험 이미징 시장 임상시험 이미징 시장 - 업계 상황
- 무기적 성장 전략
- 유기적 성장 전략
제12장 기업 개요
- eResearch Technology Inc
- Calyx Inc
- ICON PLC
- VIDA Diagnostics Inc
- WCG Clinical Inc
- BioTelemetry Inc
- Medical Metrics Inc
- Medpace Holdings Inc
- IXICO plc
제13장 부록
KSA 23.10.19The North America clinical trial imaging market is expected to grow from US$ 704.94 million in 2023 to US$ 1,025.61 million by 2028; it is estimated to register a CAGR of 7.8% from 2023 to 2028.
Spur in Number of CROs Offering Medical Imaging Services Fuels North America Clinical Trial Imaging Market
Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, a few of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). A few examples of iCROs include Keosys Medical Imaging and Medica Group PLC. CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall North America clinical trial imaging market.
North America Clinical Trial Imaging Market Overview
The North America clinical trial imaging market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trial imaging. The market growth in the region is attributed to the US emerging as a leading clinical research destination and a growing number of innovative product launches by companies for applications in clinical trials. The US has emerged as a leading clinical research destination. Approximately half of the total clinical trials conducted globally are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial-generated data.
North America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
North America Clinical Trial Imaging Market Segmentation
The North America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.
Based on modality, the North America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.
Based on offering, the North America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.
Based on end user, the North America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.
Based on country, the market is segmented into US, Canada, and Mexico. The US dominated the market share in 2023.
BioTelemetry Inc, Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Medpace Holdings Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the North America clinical trial imaging market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America clinical trial imaging market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies
- develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the clinical trial imaging market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 North America Market Segmentation
- 1.3.1 North America Clinical Trial Imaging Market - by Modality
- 1.3.2 North America Clinical Trial Imaging Market - by Offering
- 1.3.3 North America Clinical Trial Imaging Market - by End User
- 1.3.4 North America Clinical Trial Imaging Market - by Country
2. North America Clinical Trial Imaging Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Clinical Trial Imaging Market - Market Landscape
- 4.1 Overview
- 4.1.1 North America PEST Analysis
- 4.2 Expert Opinion
5. North America Clinical Trial Imaging Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
- 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
- 5.2 Market Restraints
- 5.2.1 High Investment and Standardized Infrastructure Requirements
- 5.3 Market Opportunities
- 5.3.1 In-Silico Imaging Clinical Trials
- 5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
- 5.5 Impact Analysis
6. North America Clinical Trial Imaging Market
- 6.1 North America Clinical Trial Imaging Market Revenue Forecast and Analysis
7. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality
- 7.1 Overview
- 7.2 North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
- 7.3 Tomography
- 7.3.1 Overview
- 7.3.2 Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Ultrasound
- 7.4.1 Overview
- 7.4.2 Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Positron Emission Tomography
- 7.5.1 Overview
- 7.5.2 PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 X-Ray
- 7.6.1 Overview
- 7.6.2 X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7 Echocardiography
- 7.7.1 Overview
- 7.7.2 Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8 Magnetic Resonance Imaging
- 7.8.1 Overview
- 7.8.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering
- 8.1 Overview
- 8.2 North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
- 8.3 Trial Design Consulting Services
- 8.3.1 Overview
- 8.3.2 Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Read Analysis Services
- 8.4.1 Overview
- 8.4.2 Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Operational Imaging Services
- 8.5.1 Overview
- 8.5.2 Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Imaging Software
- 8.6.1 Overview
- 8.6.2 Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User
- 9.1 Overview
- 9.2 Pharmaceutical and Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3 Contract Research Organizations
- 9.3.1 Overview
- 9.3.2 Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis
- 10.1 Overview
- 10.1.1 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
- 10.1.1.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
11. Clinical Trial Imaging Market - Industry Landscape
- 11.1 Overview
- 11.2 Inorganic Growth Strategies
- 11.2.1 Overview
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
12. Company Profiles
- 12.1 eResearch Technology Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Calyx Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 ICON PLC
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 VIDA Diagnostics Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 WCG Clinical Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 BioTelemetry Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Medical Metrics Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Medpace Holdings Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 IXICO plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
